Platform
AI BioX™ Platform
The AI BioX™ Platform features two key components, AIPharmX™ and AIChemX™, designed to explore a broader chemical space more efficiently and cost-effectively. These modules significantly decrease the need for wet experiments, thus speeding up the drug discovery process.
System
Artificial intelligence for every step of pharmaceutical research and development
AIPharmXTM Platform
With over 100 AI models that can be seamlessly interconnected via workflows, customized solutions are crafted based on customer requirements. Problem-oriented strategy recommendations inspire experts to develop innovative ideas for directed molecular design, high-throughput evaluation, and supplementary synthesis and testing stages.
Read More
AIChemXTM Platform
Leveraging the physical principles of quantum mechanics, molecular mechanics, and statistical mechanics, we developed UniX-Pose for binding mode prediction and UniX-FEP for affinity prediction. These tools aid in molecular design, evaluation, and optimization.
Read More
Novel Targets
Novel Molecules
Druggability Evaluation
TMPlatform
Our AI BioX™ Platform harnesses millions of data samples and diverse data types to uncover disease signatures and pinpoint the most promising targets from hundreds of millions of existing molecules or those generated de novo according to preferred parameters.
Professional Insights
De-novo Drug Design
Data Feedback
If You Have Any Project. Please,
Computational Chemistry
Shape the future of chemistry
Revolutionize chemistry research with AI, digital technology, and automation. Propel innovation in the chemical and pharmaceutical sectors.
Revolutionize chemistry research with AI, digital technology, and automation. Propel innovation in the chemical and pharmaceutical sectors.
-
Total Project
-
Happy Clients
-
Total Employed
-
Compounds
-
Post Service Assistance
AIChemX™ Platform
AIChemX™ significantly enhances success rates in synthesis route design and prediction using diverse synthesis strategies.
-
Synthesis of Compound Library
Catalyst Screening
Optimization of Reaction Conditions
-
Our Vission
Our vission is to become a global leader in AI-driven biological innovation, significantly contributing to science and society.
Read More -
Our Story
With years of experience, CD ComputaBio can provide customers with professional solutions applying artificial intelligence for pharmaceutical projects.
Read More -
Our Mission
We are dedicated to developing AI-driven solutions that enable more accurate, efficient, and comprehensive analysis of biological data.
Read More
Grow Up Your Business With Us
Choose CD ComputaBio today and open doors to new opportunities
Get a Quote
Our Clients Feedback
"The deep learning models developed by CD ComputaBio have provided unparalleled insights into molecular interactions that were previously beyond our reach. Their expertise has helped us achieve breakthroughs in our research projects."
—— Dr. Linda Roberts